Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

Resultado final

Independent boards (EAB and SAB) up and constituted

Report on the composition of these boards.

Policy for third party access and use of project results

On month 1, it will be an agreement on the key principles regarding 3rd party access allowing to discuss contract with non-EORTC groups. The full policy will be available by month 6.

Leaflet in lay language

Leaflet explaining the project in lay language.

First newsletter circulated

First newsletter

Publicaciones

Yes, IMMUcan! Unraveling the human tumor microenvironment

Autores: Henoch Hong, Robin Liechti, Marie Morfouace
Publicado en: Immuno-Oncology Insights, Edición 2021; 2(5),, 2021, Página(s) 301–309, ISSN 2059-7800
Editor: BioInsights Publishing Ltd
DOI: 10.18609/ioi.2021.038

Meta-analysis of human cancer single cell RNA-seq datasets using the IMMUcan database.

Autores: Jordi Camps; Floriane Noël; Robin Liechti; Lucile Massenet-Regad; Sidwell Rigade; Lou Götz; Caroline Hoffmann; Elise Amblard; Melissa Saichi; Mahmoud M. Ibrahim; Jack Pollard; Jasna Medvedovic; Helge G. Roider; Vassili Soumelis
Publicado en: Cancer Research, 2023, ISSN 1538-7445
Editor: AACR
DOI: 10.1158/0008-5472.can-22-0074

Resultado final

Publicaciones

Compartir esta página

Descargar